Validive clonidine Lauriad: Completed Phase II enrollment

BioAlliance completed enrollment of 183 patients in a double-blind, placebo-controlled, international Phase II trial evaluating 50 and 100 µg buccal Validive once daily for up to 8 weeks. Validive has...